Lorna M. Secker‐Walker

3.2k citations

56 papers · 2.4k indexed · 1 hit paper · h-index 23

Hematology top 0.5%
- Acute Myeloid Leukemia Research 29
- Chronic Myeloid Leukemia Treatments 20
- Hematopoietic Stem Cell Transplantation 7
Public Health, Environmental and Occupational Health top 0.5%
- Acute Lymphoblastic Leukemia research 37
Genetics top 2%
- Genomic variations and chromosomal abnormalities 14
- Chronic Lymphocytic Leukemia Research 12
Pediatrics, Perinatology and Child Health top 5%
Genetics top 5%
- Genomic variations and chromosomal abnormalities 14
- Chronic Lymphocytic Leukemia Research 12
Cancer Research
- Cancer Genomics and Diagnostics 7
Immunology
- Immunodeficiency and Autoimmune Disorders 3

Co-authors: R. M. Hardisty Mary Martineau Christine J. Harrison SylviaD. Lawler Anthony V. Moorman Atul Mehta Letizia Foroni H. G. Prentice
Cited by: Hematology Public Health, Environmental and Occupational Health Genetics
Journals: British Journal of Haematology (14 papers)Genes Chromosomes and Cancer (6 papers)Leukemia Research (4 papers)
Partner nations: United Kingdom United States Ireland

In The Last Decade

Lorna M. Secker‐Walker

56 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Lorna M. Secker‐Walker

Since Specialization

Citations

This map shows the geographic impact of Lorna M. Secker‐Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorna M. Secker‐Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorna M. Secker‐Walker more than expected).

Fields of papers citing papers by Lorna M. Secker‐Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorna M. Secker‐Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorna M. Secker‐Walker. The network helps show where Lorna M. Secker‐Walker may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lorna M. Secker‐Walker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lorna M. Secker‐Walker Line = papers co-authored together Lorna M. Secker‐Walker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trialbreakdown → Blood ·Anthony V. Moorman,Christine J. Harrison,Georgina Buck,Sue Richards,Lorna M. Secker‐Walker,Mary Martineau,Gail H. Vance,Athena M. Cherry,Rodney R. Higgins,Adele K. Fielding,Letizia Foroni,Elisabeth Paietta,Martin S. Tallman,Mark R. Litzow,Peter H. Wiernik,Jacob M. Rowe,Anthony H. Goldstone,Gordon W. Dewald	2006	502
2	The Leukaemia Research Fund/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management British Journal of Haematology ·Christine J. Harrison,Mary Martineau,Lorna M. Secker‐Walker	2001	60
3	Acute myeloblastic leukaemias of FAB types M6 and M4, with cryptic PML/RARα fusion gene formation, relapsing as acute promyelocytic leukaemia M3 British Journal of Haematology ·Andres Virchis,Катерина Сефіханова,Hassan Abbas,P. W. Bridgman,S. Yue,Lorna M. Secker‐Walker,H. G. Prentice,Atul Mehta	2001	9
4	FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission Bone Marrow Transplantation ·Miriam Deane,Mickey Koh,Letizia Foroni,Kyrkou Christos,A. V. Hoffbrand,Mark Lawler,Lorna M. Secker‐Walker,H. G. Prentice	1998	19
5	General Report on the European Union Concerted Action Workshop on 11q23, London, UK, May 1997 Leukemia ·Lorna M. Secker‐Walker,(unknown)	1998	44
6	The importance of cytogenetics and associated molecular techniques in the management of patients with leukaemia Clinical Oncology ·Christine J. Harrison,Lorna M. Secker‐Walker	1998	6
7	Fluorescence In Situ Hybridization Reveals Trisomy 2q by Insertion into 9p in Hepatoblastoma Cancer Genetics and Cytogenetics ·Erzsébet Balogh,S Swanton,Csongor Kiss,Nikola Terzić,Lorna M. Secker‐Walker,Éva Oláh	1998	13
8	Single-cell trisomy in hematologic malignancy Cancer Genetics and Cytogenetics ·T. Piaia,Atul Mehta,Lorna M. Secker‐Walker	1995	8
9	Two Down syndrome patients with an acquired translocation, t(8;14)(q11;q32), in early B-lineage acute lymphoblastic leukemia Cancer Genetics and Cytogenetics ·Lorna M. Secker‐Walker,Jacqueline Hawkins,H. G. Prentice,P H Mackie,Nyla A. Heerema,Arthur J. Provisor	1993	8
10	Inversion of chromosome 16 with the Philadelphia chromosome in acute myelomonocytic leukemia with eosinophilia Cancer Genetics and Cytogenetics ·Lorna M. Secker‐Walker,Gareth J. Morgan,Toon Min,G. John Swansbury,Jeffrey M. Craig,Toshiyuki Yamada,Yasemin Deringöl,M. Jerić,W. D. Pierce,V. E Viljoen,Melinda Cannuli,D Catovsky	1992	37
11	Karyotype and T‐cell receptor expression in t‐lineage acute lymphoblastic leukemia Genes Chromosomes and Cancer ·Lorna M. Secker‐Walker,姚培洪,Akbas B. Mirci A,Dario Campana,Elaine Coustan‐Smith	1992	10
12	Ewing's sarcoma t(11;22) in a case of acute nonlymphocytic leukemia Cancer Genetics and Cytogenetics ·Jacqueline Hawkins,Jeffrey M. Craig,Lorna M. Secker‐Walker,H. G. Prentice,Atul Mehta	1991	10
13	The use of fluorodeoxyuridine synchronization for cytogenetic investigation of acute lymphoblastic leukemia Cancer Genetics and Cytogenetics ·Владимир Владиславович Шадрин,Lorna M. Secker‐Walker	1991	5
14	Leukemia characterized by multiple sub‐clones with unbalanced translocations involving different telomeric segments: Case report and review of the literature Genes Chromosomes and Cancer ·Barsha Deo,Mark Layton,Lorna M. Secker‐Walker	1990	34
15	Demonstration of acquired hemizygosity and clonality in acute lymphoblastic leukemia with chromosome 7 abnormalities using hypervariable DNA probes Genes Chromosomes and Cancer ·Toshiyuki Yamada,Barsha Deo,Mary Martineau,Lorna M. Secker‐Walker	1990	7
16	Clonal Evolution in Ph-Negative, bcr-Positive Chronic Myeloid Leukaemia before and after Bone Marrow Transplantation Acta Haematologica ·Lorna M. Secker‐Walker,H.M. Cooke,Peter Browett,John D. Norton,J Ruggiero,A. G. Prentice,賢一西沢	1989	3
17	Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long‐term follow‐up British Journal of Haematology ·Lorna M. Secker‐Walker,Judith M. Chessells,Windri Mauludi,G. John Swansbury,Susan Richards,Sylvia D. Lawler	1989	61
18	Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia Cancer Genetics and Cytogenetics ·Clara D. Bloomfield,Lorna M. Secker‐Walker,洪明陈,Herman Van den Berghe,Albert de la Chapelle,Tapani Ruutu,Giuliana Alimena,O. Margaret Garson,H M Golomb,J D Rowley,Yasuhiko Kaneko,J. Whang‐Peng,E. L. Prigogina,Preben Philip,A. A. Sandberg,SylviaD. Lawler,Felix Mitelman	1989	126
19	Differentiation induction in myelodysplasia and acute myeloid leukaemia: Use of synergistic drug combinations Leukemia Research ·G. E. Francis,G J Mufti,S. Knowles,J. J. Berney,卓也小河,Lorna M. Secker‐Walker,Terry J. Hamblin	1987	17
20	Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis. BMJ ·Lorna M. Secker‐Walker,SylviaD. Lawler,R. M. Hardisty	1978	157

About Lorna M. Secker‐Walker

Lorna M. Secker‐Walker is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics, having authored 56 papers that have together received 2.4k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (37 papers), Acute Myeloid Leukemia Research (29 papers), Chronic Myeloid Leukemia Treatments (20 papers), Genomic variations and chromosomal abnormalities (14 papers), Chronic Lymphocytic Leukemia Research (12 papers), Cancer Genomics and Diagnostics (7 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Hematology (1.8k citations), Public Health, Environmental and Occupational Health (1.7k citations) and Genetics (394 citations). Lorna M. Secker‐Walker has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include R. M. Hardisty, Mary Martineau, Christine J. Harrison, SylviaD. Lawler, Anthony V. Moorman, Atul Mehta, Letizia Foroni, H. G. Prentice, Jill Durrant and G Harrison. Their work appears in journals such as British Journal of Haematology, Genes Chromosomes and Cancer, Leukemia Research, Cancer Genetics and Cytogenetics and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact